Direct antiviral agent treatment of chronic hepatitis C results in rapid regression of transient elastography and fibrosis markers fibrosis‐4 score and aspartate aminotransferase‐platelet ratio index
Jacqueline Bachofner(University Hospital Zurich), Joachim C. Mertens(GastroZentrum Hirslanden Zürich), Benedetta Terziroli Beretta‐Piccoli(Ente Ospedaliero Cantonale), Beat Müllhaupt(University Hospital of Zurich), Adriana Baserga(Epatocentro Ticino), Anja Moncsek(University Hospital of Zurich), Patrizia Künzler‐Heule(University of St.Gallen), Jan Fehr(University Hospital of Zurich), David Semela(Kantonsspital St. Gallen), Arne Kröger(University Hospital Zurich), Irina Bergamin(University of St.Gallen), Dominique L. Braun(University of Zurich), Burkhardt Seifert(Omega Consult (Slovenia)), Piero V. Valli(University Hospital of Zurich), Lorenzo Magenta(Epatocentro Ticino)
Cited by 276
Related Papers
Cholangiocarcinoma 2020: the next horizon in mechanisms and management
|Nature Reviews Gastroenterology & Hepatology|2020|2.5k
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
|Nature Reviews Gastroenterology & Hepatology|2016|1.4k
NASH limits anti-tumour surveillance in immunotherapy-treated HCC
|Nature|2021|1.3k